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Atomic force microscopePeptide lipidation has proven to be an inexpensive and effective strategy for designing next-generation peptide-
based drug compounds. In this study, the effect of the acyl chain length of ultrashort LiPs (CX-KYR-NH2; X = 10,
12, 14 and 16) on their bacterial killing and membrane disruption kinetics was investigated. The geometric
mean of the minimum inhibitory concentration (MIC) values for 4 pathogenic bacterial strains was 25 μM, with
a selectivity index of 10.24 for C14-KYR-NH2. LiPs at all concentrations exhibited no cytotoxicity towards human
erythrocytes, but towards Vero cells at 80 μM. All the LiPs adopted secondary structure in a membranemimicking
environment. C14-KYR-NH2 aggregated above 256 μM,while C16-KYR-NH2 did above 80 μM. All LiPs showed outer
membrane permeabilizationwithin 3min after treatment, yet the extent and kinetics of innermembrane penetra-
tion and depolarizationwere dependent on the acyl chain length. Cell death subsequently occurredwithin 10min,
and killing activity appeared to correlate most with depolarization activity but not with outer or inner membrane
permeability. AFM imaging of cells treated with C14-KYR-NH2 revealed rupture of the cell surface and cytosolic
leakage depending on the length of incubation. This study highlights and follows the progression of events that
occur during themembrane disintegration process over time, and determines the optimal amphipathicity of ultra-
short LiPswith 12–14 carbon atoms for thismembrane disrupting activity. The fast acting bactericidal properties of
ultrashort LiPs with optimal chain lengths make them promising candidates for drug lead compounds.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The emergence of resistant microbes to classical antibiotics has
prompted the study and development of alternative agents as a new
generation of antimicrobial compounds. Alternatives to classical antibi-
otics are in need and peptide antibiotics such as antimicrobial peptides
(AMPs) have shown signiﬁcant promise as potential candidates for fu-
ture therapeutics. The advantages of AMPs over conventional antibiotics
include, but are not limited to, a broader spectrum of activity, non-
receptor mediated modes of action, and minimal induction of drug re-
sistance. AMPs were initially isolated more than two decades ago from
various organisms, including insects, hemolymphs, frogs andmammali-
an neutrophil granules [1–4]. They are essential and evolutionarily con-
served elements of the innate defense system of these organisms. AMPs
generally consist of 12–50 aa that are mixed between hydrophobic andy, Faculty of Science, Khon Kaenhydrophilic groups, allowing for solubility in both aqueous and lipid
phases. They have a net positive charge of 2–9 and most of them
adopt amphipathic structures when bound on the membrane. In the
past decade much focus has been centered on modiﬁcation of AMPs to
improve their antimicrobial activity, increase their in vivo efﬁcacy and
retention, and lower the cost of theirmanufacture [5,6]. Generally,mod-
ifying the peptides by changing the amino acid sequence or by alternat-
ing their order within the sequence has been shown to increase
antimicrobial activity [3,7,8]. However, other peptide modiﬁcations
are interesting as well. Linking peptides with other biological macro-
molecules such as sugars or lipids has proven to yield higher antimicro-
bial activity compared to the parent non-linked peptides [8,9].
Natural lipopeptides (LiPs) are produced nonribosomally in bacteria
and fungi during cultivation in various carbon sources. The structure
consists of a hydrophobic lipidmoiety covalently attached to hydrophil-
ic peptides of 6–7 amino acids. Some of them are highly active against
antibiotic-resistant pathogenic bacteria. For instance, polymyxin B,
one of themost studied lipopeptides, has been long used to treat topical
and urinary tract infection [10] and daptomycin has been approved by
the Food and Drug Administration for topical infections [11]. Although
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these native LiPs are non-cell-selective and can cause severe cytotoxic-
ity for mammalian cells. Synthetic LiPs have attracted considerable in-
terest as the alternative to classical AMPs and native LiPs due to their
non-cytotoxic activity, high efﬁcacy and retention in vivo, and lower
cost of manufacture [12]. Synthetic LiPs consist of a short linear or cyclic
peptide sequencewith a positive net charge and a fatty acid chain (8–18
carbon chain length) attached at the N-terminus through a covalent
bond [8,9]. Addition of the carbon chain onto the short AMP has been
proven to yield more than a 100-fold increase in antimicrobial activity
for some LiPs and reduced the cytotoxicity towards mammalian cells
compared to the parent peptides or other associated antibacterial/anti-
fungal compounds. Some examples of this are C12-OOWW-NH2, C14-
OOWW-NH2, C12-KLLK-NH2 and C16-KGGK-NH2, where O is ornithine
amino acid [7–9]. Among the synthetic LiPs reported, the shortest LiP
was composed of 2–4 amino acids linked to a fatty acid (12–16 carbon
chain) [9,13]. The fatty acid tail has been shown to compensate for the
hydrophobicity seen in the classical AMPs and a length of 2–4 amino
acids has been shown to be sufﬁcient for bactericidal potency of these
LiPs [9,13–15].
Themode of action of LiPs is believed to be similar to that of conven-
tional AMPs,where the antimicrobial activity is governed by the optimal
hydrophobicity of the peptide and its ability to form a speciﬁc confor-
mation with amphipathic structure upon membrane binding [16]. LiPs
remain in a soluble oligomeric form in solution, and bind to the cell sur-
face via electrostatic interactions. LiPs accumulate on the cell surface
until reaching a speciﬁc concentration called the lipid phase partitioning
threshold. At concentrations above this threshold, LiPs can traverse
through polysaccharides barriers via the microorganism's self-
promoted uptake mechanism to reach the outer and inner membrane
of Gram negative bacterial cells, and the cytoplasmic membrane of
Gram positive bacterial cells [16,17]. The inner/cytoplasmic membrane
is the major target of LiPs where permeabilization and depolarization
take place, leading to membrane disintegration and eventually cell
death [8]. Despite extensive investigation on the effect of acyl chain
length and peptide composition of LiPs on bactericidal potency, much
less attention has been given to the mechanism of action. As a conse-
quence, the optimization of LiPs for better activity could lack the funda-
mental or concrete understanding of how acyl chain length can affect
the activity and could hamper the possibility of designing LiPs with
high therapeutic potency.
KYR, one of the shortest AMPs reported by far, is the amino acid se-
quence (balpha N 139–141) of the bovine hemoglobin alpha chain
strand. Itwas part of the longer amino acid sequence (balpha N 137–141)
137–141) that was obtained from hydrolyzing the hemoglobin alpha
chain. Based on the sequence (balpha N 137–141), KYR was the shortest
synthesized sequencewith aminimum inhibitory concentration (MIC) in
the range of 1–4 μM [1]. With such high activity, we expected that mod-
ifying KYR through amidation (−NH2) of the C-terminus and acylation of
the N-terminus with a lipid functional group might yield better antimi-
crobial activity. We were also interested in elucidating the mechanism
of the effects of the acyl chain length on the antimicrobial activity in de-
tail. In this study, we investigated the antimicrobial activity and mode
of action of KYR-NH2 and its lipid modiﬁed forms with decanoic acid
(C10), lauric acid (C12), myristic acid (C14), or palmitic acid (C16) attached
at the N-terminus against 4 strains of pathogenic bacteria, including the
multidrug resistant Klebsiella pneumonia. The time-course killing activity
as a function of the acyl chain length of the LiPswas determined. The geo-
metric mean of MIC and the selectivity index was shown. The structure
and aggregation tendency of the LiPs were determined using circular di-
chroism and dynamic light scattering, respectively. The membrane dis-
ruptive action of the LiPs was observed using ﬂuorescent probes in
order to monitor outer/inner membrane permeabilization and mem-
brane depolarization in a timely manner. Cell morphology after treat-
ment with the LiPs was observed by atomic force microscopy. From
these results, a step by step model of LiPs action was determined.2. Materials and methods
2.1. Materials and cell culture
LiPs were synthesized by Fmoc solid-phase method at GL Biochem
(Shanghai) Ltd. (Shanghai, China). N-phenyl-1-naphthylamine (NPN)
was purchased from Bio-Rad (Hercules, CA). Polymyxin Bwas purchased
from Sigma-Aldrich (St. Louis, MO). Luria-Bertani broth (LB) and nutrient
agar (NA) were purchased from HiMedia (Mumbai, India). The LIVE/
DEAD Light™ bacterial-viability kit was purchased from Invitrogen®
(Grand Island, NY). Bis-(1,3-Dibutylbarbituric Acid)Trimethine Oxonol
(DiBAC4(3)) was purchased from Molecular Probe®, Inc. (Grand Island,
NY). Pathogenicmicroorganismswere kind gifts from the Thammasirirak
Laboratory, Protein and Proteomics Research group, Khon Kaen Universi-
ty. The following strains were used in this study: Staphylococcus aureus
ATCC 25923, Staphylococcus epidermidis ATCC 12228, Escherichia coli
MG 1655 ATCC 700926, E. coli O157:H7 ATCC 43895, and K. pneumonia
ATCC 17736. All microbial strains were stored at−70 °C in 20% glycerol
in an Eppendorf tube. The bacteria were streaked on NA and then cul-
tured at 37 °C overnight. Colonies were picked and cultured in LB broth
(10 g of tryptone, 5 g of yeast extract, and 10 g of NaCl per liter) at
37 °C in an incubator overnight and then subcultured at 37 °C in a
200 rpm shaker-incubator for 2–3 h to yield a mid-logarithmic growth
phase culture.
2.2. Peptide design and synthesis
LiPs were synthesized by Fmoc solid-phase method at GL Biochem
(Shanghai) Ltd. (Shanghai, China). The lipophilic acid was attached to
the N terminus of a resin-bound peptide by standard Fmoc chemistry,
followed by peptide cleavage from the resin and puriﬁcation by
reversed-phase high-performance liquid chromatography (RP-HPLC;
N98%). The LiP compositionswere conﬁrmed by electrospray ionization
mass spectroscopy (ESI-MS) and amino acid analysis. LiPs were dis-
solved in 10% DMSO at a concentration of 1 mg/mL and the peptide so-
lutions were stored at −20 °C before subsequent antibacterial and
structural assessments.
2.3. CD analysis
All spectra were collected on a Jasco J-815 CD spectrophotometer
(JASCO, Easton, MD) using a circular quartz cuvette with a path length
of 1.0 mm from 198 nm to 260 nm at room temperature. To investigate
the conformational changes induced by a secondary structure promot-
ing agent, the powder LiPs were dissolved in 5% TFA to make a stock
of 256 μM. The stockwas diluted to 20 μM in 10mM sodium phosphate
buffer, pH 7.4 or 50% triﬂuoroethanol (TFE) when used. Baseline spectra
for each solvent were obtained prior to the peptide spectra. The CD
spectra were recorded with a 0.5 nm bandwidth and a scan speed of
50 nm/min for 10 repeats. CDdata are expressed as themean residue el-
lipticity in deg·cm2·dmol−1. The content of the secondary structure
was analyzed with CONTIN LL program [18].
2.4. Analysis of tendency of aggregation
Dynamic light scattering (DLS) was performed to characterize the
sizes of the peptide aggregates in solution using the Zetasizer Nano ZS
(Malvern), Research Instrument Center Khon Kaen University. Follow-
ing pervious method [18,19], the 256 μM stock of LiPs in 5% TFAwas di-
luted to a series of concentration in 10 mM sodium phosphate buffer,
pH 7.4. Each sample of 1.5 mL was transferred to a square cuvette for
DLS measurement. Data were collected and presented as the mean of
three repeats.
The morphology of the peptide/LiPs was imaged by atomic force mi-
croscope (AFM) according to previously described methods [18,19].
Brieﬂy, each concentration of peptide/LiPs (20, 40, 80, 128, and 256 μM)
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LiP solution was placed on a glass slide and dried at room temperature.
Then, the morphology of the peptide/LiPs was imaged in tapping mode
by atomic forcemicroscope (XE-120 Park Systems), Research Instrument
Center, KhonKaenUniversity. Applied Si probeswere used for cantilevers
and a resonance frequency of 200–500 kHz. All height images were
collected.
2.5. Minimum inhibitory concentration (MIC) measurements
The MICs of the peptides and drugs against ﬁve bacterial strains
were determined by the broth microdilution method as described pre-
viously [8,20,21]. Brieﬂy, a range of concentrations (1.25, 2.5, 5, 10, 20,
40, 80 and 160 μM) of the LiPs was prepared by serial dilution and
added to an equal volume of bacterial solution (100 μL) in each well of
a 96-well plate. The plates were incubated at 37 °C and read after
18 h. The MIC was deﬁned as the concentration at which no microbial
growth was observed visually or spectrophotometrically via readings
of optical density (OD) at 600 nm (microplate reader model 680, Bio-
Rad, USA). Growth media containing only microbial cells was used as
the negative control. Each MIC test was carried out in triplicate.
2.6. Bacteria viability measurement
Time-kill experiments against three Gram-negative bacterial strains
and two Gram-positive bacterial strains using methods described previ-
ously [22,23] and viability were measured with a LIVE/DEAD BacLight™
bacterial-viability kit (Invitrogen) using the protocol recommended by
the manufacturer. Brieﬂy, mid-log-phase cultures of these strains were
ﬁrst adjusted to the same cell density at OD655. The cells were harvested
andwashed three times in potassium phosphate buffer (PPB). The killing
was initiated by adding an aliquot of cell suspension (1 × 107 CFU/mL) to
75 μL/well of PPB containing different concentrations of LiPs (1.25, 2.5, 5,
10, 20, 40, 80 and 160 μM) and 75 μL/well of 2× dye kits solution was
added to a 96-well plate. Samples were incubated at 37 °C in the dark
for 90 min and ﬂuorescence was measured every 10 min for 90 min,
while samples without the peptide were used as controls. The excitation
and emission wavelengths were 485 nm and 530 nm for green ﬂuores-
cence (em1) and 603 nm for red ﬂuorescence (em2), respectively. The
ratio of live cells comparing to dead cells was calculated as follows:
RatioG/R = Fcell, em1 / Fcell, em2, where Fcell, em1 is the integrated intensity
of the portion of green ﬂuorescence and Fcell, em2 is the integrated inten-
sity of the portion of red ﬂuorescence. Percentage of dead cells was calcu-
lated as follows: (1− RatioG/R) ∗ 100
2.7. Eukaryotic cell toxicity testing
Hemolytic activity of peptide/lipopeptide was assayed spectrophoto-
metrically for their ability to induce hemolytic according to the Catiau, L
et al. [1]. Brieﬂy, human red blood cells (hRBCs) were isolated via centri-
fugation,washed three timeswith PBS, and then suspended to 4% (v/v) in
PBS. 100 mL hRBC suspensions were added into each well of a sterilized
96-well plate. To each well was added 100 □L peptide solution, and the
plates were incubated for 1 h at 37 °C and centrifuged at 1000 g for
5 min. 100 □L aliquots of supernatant were transferred to fresh 96-well
plates and hemoglobin release was monitored with a SpectraMax M5
ﬂuorescence microplate reader by measuring the absorbance at
405 nm. 0% and 100% hemolysis was determined in PBS and 0.1% Triton
X-100, respectively.
A cell viability assay (MTT assay) is one of the most widely used
methods for toxicity analysis [24]. Brieﬂy, Vero cells (kidney epithelial
cells) were seeded at 5 × 103 cells per well and incubated in RPMI
with or without the tested LiPs for 24 h at 37 °C, 5% CO2. After exposure
the test medium was discarded, and the cells were incubated with
100 μl of MTT solution (0.5 mg/ml MTT diluted in DMSO) for 4 h at
37 °C, 5% CO2. Subsequently, the MTT solution was discarded and100 μl of DMSO was added to each well. Optical density (OD) was
read on a microplate reader at 570 nm, with a reference at 655 nm.
Cell viability for each treatment was calculated as the ratio of the
mean OD of replicated wells relative to that of the control (only cell cul-
ture medium added) [9,25,26].
2.8. NPN outer membrane permeabilization assay
The outer membrane permeabilization activity of the ultrashort
peptide/lipopeptide was determined by the NPN uptake assay of Loh
et al. [27,28]. Brieﬂy, an overnight culture of bacteria was diluted in LB
medium and grown to an OD655 ~ 0.5. The cells were harvested, washed,
and resuspended in the same volume of buffer (5 mM HEPES, pH 7.2,
5 mM KCN). For the NPN assay, 1 mL of cells and 0.02 mM N-phenyl-1-
naphthylamine (NPN)weremixed, and the initial ﬂuorescencewasmea-
sured using a SpectraMaxM5 ﬂuorescencemicroplate reader. The excita-
tion and emission wavelengths were 350 nm and 429 nm, respectively.
Peptide/lipopeptide was added to the mixture to a ﬁnal concentration
of 20 μM. Increases in ﬂuorescence due to partitioning of NPN into the
outer membrane was recorded over time until no further increase in in-
tensitywas observed. Fluorescence increasewas reported as a percentage
of the ﬂuorescence measured after Triton-X 100 treatment. The ﬂuores-
cence blank was NPN with bacteria only.
2.9. Inner membrane permeabilization assay
To assess the ability of SYTOX®Green to alter the permeability of the
inner membrane, experiment was performed according to Li et al. with
somemodiﬁcations [29]. Brieﬂy, bacteria cells were grown to mid loga-
rithmic phase at 37 °C, washed three times and suspended in PBS buffer
(1 × 107 cells/mL) containing 10% LB medium. Aliquots of 90 μL of this
cell suspension were deposited in each well of a standard 96-well
plate. Then, 10 μL of the 20 μM ﬁnal concentration peptide containing
5 μM SYTOX® Green was added to the wells. The time-dependent in-
crease in ﬂuorescence excited by binding of the cationic dye to intracel-
lular DNA was monitored using a SpectraMax M5 ﬂuorescence
microplate reader. The excitation and emission wavelengths were
504 nm and 523 nm, respectively.
2.10. Membrane depolarization using DiBAC4(3)
Bacterialmembrane potentialwas determined by using the lipophil-
ic anionic membrane potential-sensitive dye bis-1,3-(dibutylbarbituric
acid)trimethine oxonol DiBAC4(3) (Molecular Probes, Inc.) by themeth-
od of Mason et al. [30,31] with some modiﬁcations. Brieﬂy, bacterial
cells incubated overnight in LB medium were diluted 1:100 with fresh
medium and incubated at 37 °C to log-phase growth. Cells were har-
vested to give a density of 1 × 107 cells/mL and washed three times
and resuspended in 5mMHEPES buffer. Bacteria were incubated in dif-
ferent concentrations of LiPs (20 and 40 μM ﬁnal concentrations LiPs)
containing DiBAC4(3) at a ﬁnal concentration of 10 mg/mL. The dose–
response assay wasmonitored using a SpectraMaxM5 ﬂuorescencemi-
croplate reader after 15 and30min of incubation at 37 °C. The excitation
and emission wavelengths were 493 nm and 516 nm, respectively. The
potential membrane activity of the LiPs is expressed as follows:
% membrane depolarization ¼ 100 Fp−F0
 
= FPMB−F0ð Þ
 
;
where F0 is the stableﬂuorescence value after addition of theDiBAC4(3),
Fp is the ﬂuorescence value of the LiPs for 15 and 30 min, and FPMB the
ﬂuorescence signal of polymyxin B.
2.11. Bacterial attachment to glass slides for AFM imaging
Colonies were picked and cultured in LB broth at 37 °C in an incuba-
tor overnight and then subcultured at 37 °C in a 200 rpm shaker-
Table 1
Sequence analysis and susceptibilities of designed peptide/LiPs.
Peptide/LiPs Sequence Measured MW a (g/mol) Retention time (min) Net charge MIC/MBC
(μM in upper panel and μg/ml in lower panel)b
GMc (μM) HC10d (μM) SIe
S. aureus ATCC
25923
S. epidermidis ATCC
12228
E. coliMG 1655
ATCC 700926
E. coli O157:H7
ATCC 43895
s ATCC 17736
KYR-NH2 LysTyrArg-NH2 464.57 8.518 +2 N160/N160
N74.3/N74.3
80/160
37.1/74.3
40/40
18.6/18.6
40/40
18.6/18.6
80/160
37.1/74.3
80 N256 3.2
C10-KYR-NH2 Decanoyl-LysTyrArg-NH2 618.99 12.848 +2 80/160
49.5/99.0
80/160
49.5/99.0
40/40
24.8/24.8
80/160
49.5/99.0
120/160
74.3/99.0
80 N256 3.2
C12-KYR-NH2 Lauroyl–LysTyrArg-NH2 646.99 11.687 +2 40/40
25.9/25.9
40/40
25.9/25.9
20/40
12.9/25.9
20/40
12.9/25.9
80/120
51.8/77.6
40 N256 6.4
C14-KYR-NH2 Myristoyl-LyTyrArg-NH2 674.99 16.819 +2 25/50
16.9/33.4
25/50
16.9/33.4
15/25
10.1/16.9
20/25
13.5/16.9
40/80
27.0/54.0
25 N256 10.24
C16-KYR-NH2 Palmitoyl-LysTyrArg-NH2 702.99 14.058 +2 80/160
56.2/112.5
80/160
56.2/112.5
40/80
28.1/56.2
80/80
56.2/56.2
120/160
84.4/112.5
80 N256 3.2
C14-YYY-NH2 Myristoyl-TyrTyrTyr-NH2 716.93 12.885 0 N160/N160
N114.7/N114.7
N160/N160
N114.7/N114.7
N160/N160
N114.7/N114.7
N160/N160
N114.7/N114.7
N160/N160
N114.7/N114.7
160 N256 1.6
Polymyxin Bf C55H96N16O13 · 2H2SO4 1385.61 – +5 NT NT 2.5/5
3.4/6.9
1.25/2.5
1.7/3.5
10/10
13.9/13.9
– 32 –
Gentamicinf C21H43N5O7 477.59 – 40/120
19.1/57.3
40/80
19.1/38.2
NT NT NT – NT –
NT : No testing.
a Measured by ESI-MS.
b Minimum inhibition concentration (MIC) at which 80% inhibition andminimum bactericidal concentration (MBC) of the lipopeptides were deﬁned as the concentration at which nomicrobial growthwasmeasured visually via reading of optical
density (OD) at 600 nm and counted the bacterial growth on agar plate respectively.
c Geometric mean (GM) of MIC values (μM) for the 5 microorganisms tested.
d Hemolysis concentration 10% (HC10) is deﬁned as the lowest peptide concentration (μM) that induces 10% hemolysis.
e Selectivity index (SI) is calculated as (HC10)/GM.
f Purchased from sigma-aldrich, Inc.
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Fig. 1.Themolecular structures of parental peptide, KYR-NH2 and LiPs, C10, C12, C14, C16-KYR-NH2 and C14-YYY-NH2 respectively. Color scheme: carbon (heavy gray), hydrogen (light gray),
oxygen (red), and nitrogen (blue) using ChemBioDraw Ultra 13.0 program.
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The cells were harvested, washed, and resuspended in a 0.85% NaCl
solution. A 10 ml vial of bacterial solution (1 × 109 cells/mL) was com-
bined with 300 ml of 100 mM 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide hydrochloride (pH 5.5, EDC, Pierce). The vial was agitated
for 10 min. Following EDC treatment, 300 ml of 40 mM N-
hydroxysulfosuccinimide (pH 7.5, Sulfo-NHS, Pierce) was combined
with the bacterial solution for 10 min [32,33].
Bacterial attachment to glass slides for AFM (MFP-3D-SA, Asylum
Research, Santa Barbara, USA) measurements Glass slides were rinsed
with ultrapure water (18.2 MΩcm resistivity and b10 ppb total organic
carbon, Millipore Milli-Q plus, Billerica, MA, USA), followed by
sonication for 15 min. Glass slides were immersed in 30% 3-
aminopropyltrimethoxysilane in methanol (Sigma–Aldrich, USA) for
20 min. and rinsed with methanol and ultrapure water. Bacterial solu-
tion was added to glass slides and agitated at 70 rpm for 1–2 h to pro-
mote bacterial lawn formation.
3. Results and discussions
3.1. Physical properties of the LiPs
3.1.1. LiP design and characterization
The design of LiPs with the positively charged head group and the
hydrophobic tail in this study was based on 2 known factors. 1) TheFig. 2. The CD spectra of 20 μM LiPs were measured in 10 mM sodiuspeciﬁc amino acid sequence for ultrashort peptides (2–4 aa) is required
to obtain strong antimicrobial activity. 2) Addition of the fatty acid tails
to the ultrashort peptides resulted in increasing bactericidal potency ac-
cording to the chain length and the net hydrophobicity [8,9,34–36].
Here, we chose the KYR sequence, the minimal sequence from the
human hemoglobin alpha chain reported to have potent antimicrobial
activity, as a parent ultrashort peptide [1]. We speculated that
amidation and addition of acyl tails would increase the activity of KYR.
Then later in this study, the activity-acyl chain length relationship was
further explored by the time-mannered, membrane-disruptive mode
of killing.
The KYR-NH2 sequence and its lipid modiﬁed formwere synthesized
by the solid-phase peptide synthesis using standard 9-ﬂuorenylmethoxy
carbonyl chemistry on Rink amide-4-methylbenzhydrylamine hydro-
chloride salt resin. Decanoic acid (C10), lauric acid (C12), myristic acid
(C14) and palmitic acid (C16) were conjugated to the KYR-NH2 sequence
via modiﬁed solid-phase methods. Besides CX-KYR-NH2, the uncharged
C14-YYY was also synthesized to serve as a negative control. The se-
quence and molecular weight of the peptide and LiPs were veriﬁed by
EIS-MS. Table 1 summarizes the theoretically calculated and measured
molecular weight of each peptide/LiP. All LiPs have measured molecular
weight values in agreementwith their theoretical values, suggesting that
the LiPs were successfully synthesized. The relative hydrophobicity of
designed LiPs in aqueous solution indicated that differences in hydro-
phobicity were reliably reﬂected by different HPLC retention times. Them phosphate buffer, pH 7.4 (A) or in 50% triﬂuoroethanol (B).
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Fig. 4. Bacteria viability after treatment with LiPs (A; S. aureus ATCC 25923, B; S. epidermidis ATCC 12228, C; E. coli O157:H7 ATCC 43895 and D; K. pneumoniae ATCC 17736) was deter-
mined using a LIVE/DEAD® BacLight™ bacteria viability kit. Bacterial suspensions of 1 × 107 CFU/ml treatedwith 1.25–160 μM of a series of LiPs for 90min at 37 °C. The % dead cells was
(1− RatioG / R) ∗ 100,where RatioG / R= Fcell, em1 / Fcell, em2. Fcell, em1 is the integrated intensity of the portion of green ﬂuorescence and Fcell, em2 is em1 is the integrated intensity
of the portion of red ﬂuorescence.
2357S. Nasompag et al. / Biochimica et Biophysica Acta 1848 (2015) 2351–2364amino acid sequences of the parental andmodiﬁed peptides are listed in
Table 1. The molecular structures of the LiPs series are depicted in Fig. 1.
According to the atomic calculation from ChemBioDraw Ultra 13.0 pro-
gram, the size of these LiP molecules were 2–3 nm in length. In their un-
folded state, the hydrophilic head group occupied the space about half of
the whole molecule, with C16-KYR-NH2 containing longest acyl tail.
3.1.2. Analysis of secondary structure by circular dichroism (CD)
spectroscopy
Circular dichroism (CD) has been used to study protein or peptide
conformational change in different environment, e.g., aqueous solution,
structure-promoting solvents, and lipid vesicles. Generally, AMPs is par-
tially folded in aqueous solution, but start adopting more secondary
structure with amphipathicity in structure-promoting solvents like
triﬂuoroethanol (TFE), or in the presence of lipid vesicles [37]. In this
study, to follow the folding ability of the LiPs in the structure-
promoting environment, we performed CD spectroscopy in 50%
triﬂuoroethanol (TFE) in sodium phosphate buffer, pH 7.4. The CD spec-
tra of all the LiPs in buffer indicated a disordered structure, as evidenced
by relatively ﬂat molar ellipticity from the baseline (Fig. 2A). On theFig. 3. Diameters of LiPs measured by dynamic light scattering (A) and AFM topology and heigh
with inset of 10*10 μm.other hand, while in 50% TFE, all LiPs, including KYR-NH2 adopted sec-
ondary structure as evidenced by the negative and positive change in
molar ellipticity compared to the baseline at around 198 nm and
215 nm, respectively. The analysis of the secondary structure content
by CONTIN LL program indicated that in 50% TFE KYR-NH2 and all LiPs
consisted of 51.3% turns and random coils, 31.1% β-sheets, and 11.6%
α-helix. Our results demonstrated that there was no secondary struc-
ture of KYR-NH2 and all LiPs in aqueous solution. This indicated that
the 3 amino acid long was not enough to allow the structure to be par-
tially folded, and addition of the acyl chain could not promote the sec-
ondary structure. On the contrary, around 40% of secondary structure
was found in KYR-NH2 and LiPs in the presence of TFE. This result indi-
cated that KYR-NH2 and LiPs, nomatter how short the peptide sequence
was, were able to adopt the secondary structure. The explanation owed
to the fact that addition of TFE canwithdrawwatermolecules from LiPs.
This may resulted in structural rearrangement of LiPs in either intra- or
intermolecular fashion to yield secondary structure. Our study reports
the induced-secondary structure of the ultrashort LiPs as consisting of
up to 31% β-sheet, while Domalaon, R. et al. [38] reported the
prolyprolin II-helix in the ultrashort LiPs they investigated.Most studiest images of KYR-NH2 (B), C14-KYR-NH2 (C, D) and C16-KYR-NH2 (E, F) in 2 ∗ 2 μm scan size
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amino acids, in which the peptide chains could bend and interact with
the fatty acid chain, resulting in an α-helical conformation [39,40].
3.1.3. Hydrodynamic diameter and nanostructure of LiPs
Antimicrobial LiPs exist as aggregates in solution in both visible and
invisible forms, and once bound to the membrane they dissociate via
unknown mechanism and insert into the phospholipid bilayer [16]. In
this study, the effect of acyl chain length on oligomerization state of
LiPs was determined by DLS and AFM (Fig. 3). When observed by DLS,
the size of LiPs varies from 150 to 500 nm in hydrodynamic diameter
at concentrations between 1.25–40 μM. At concentration 80 μM C14-
KYR-NH2 and C16-KYR-NH2 exhibited slightly higher aggregates, with
hydrodynamic diameter above 1000 nm (Fig. 3A). The overall results
from DLS appear to be quite random to allow us to speculate the trend
of particle diameter against the concentration of the solution. Therefore,
additional AFM images of the LiPs were taken to provide actual nano-
scale resolution topology (Fig. 3B–F, 2*2 μm with inset of 10*10 μM).
The AFM image of KYR-NH2 at 256 μM shows homogeneous topology
with an average height of 0–250 pm. The ﬂat topology indicates the ab-
sence of visible multimeric states of KYR-NH2. C14-KYR-NH2 at 80 μM
also exhibited ﬂat height between 0–0.8 nm, but a ﬁbrillar form with a
height of 2.5–7.5 nmwas found at 256 μM(Fig. 3C–D). C16-KYR-NH2 ex-
hibited droplet-likemorphologywith a height of 2–4 nmand rod-shape
topologywith a height of 40 nmat 80 and 256 μM, respectively (Fig. 3E–
F). Our ﬁndings are partially similar of that of C. Chen et al. [41] that
these LiPs could self-assemble into nanostructure like the peptide am-
phiphiles A9K, A12K, and A9K2. Although what found in their study
were mainly nanorod shape, C14-KYR-NH2 exhibited long ﬁbrillar,
dendrite-like structure with length of 1–5 μm (Fig. 3D), and C16-KYR-
NH2 had worm-like shape with length of 0.5–4 μm. Our result was in
agreement with previous studies which showed that LiPs were aggre-
gates in solution under certain concentrations [13,39,40].
3.2. Concentration-dependent and time-dependent antimicrobial activity
of LiPs
Concentration-dependent antimicrobial activity of the LiP series was
determined against a set of Gram-positive and Gram-negative strains in-
cluding S. aureus 1466, S. epidermidis ATCC 12228, E. coli O157:H7 ATCC
43895 and K. pneumonia ATCC 17736. The activity of LiPs was evaluated
by a LIVE/DEAD BacLight™ bacterial-viability kit to determine the bacte-
ria viability as shown in Fig. 4. At 40 μM, C12-KYR-NH2 and C14-KYR-NH2
had antibacterial activity towards S. aureus 1466, and S. epidermidis ATCC
12228 comparable to that of Gentamicin at 40 μM (Fig. 4A,B). This indi-
cates that the LiPs had strong activity against the representative Gram
positive strains like that of Gentamicin. The activity of these LiPs toward
E. coli O157:H7 ATCC 43895 and K. pneumoniae ATCC 17736 was not as
strong as polymyxin B (Fig. 4C,D). C12- and C14-KYR-NH2 at 40 μM
could induce death of E. coliO157:H7 ATCC 43895 up to 75% and 85%, re-
spectively (Fig. 4C), and death of K. pneumoniae ATCC 17736 up to 50%
(Fig. 4D). All LiPs except C16-KYR-NH2 displayed antimicrobial activity
2–3 folds higher than KYR-NH2. The average MIC for 4 strains tested
(the geometric index, GI) indicated that C14-KYR-NH2wasmost effective,
withGI at 25 μM.C12-KYR-NH2hadGI 40 μM, andKYR-NH2, C14-KYR-NH2
and C16-KYR-NH2 had the same GI as 80 μM (Table 1).
KYR-NH2 in our study had MIC 20-fold higher than KYR ﬁrstly re-
ported [1]. It might be due to the amidation on the C-terminus that re-
duce the activity. Besides the amidation, the discrepancy of antibacterial
activity may result from several factors including the source of peptide
synthesis, the method in determining MIC, and the pathogen strains
used. Also, one of the limitations in using the ultrashort LiPs is that
they tend to bind to proteins non-speciﬁcally, which results in more
than 4-fold loss of antibacterial activity [36]. Regarding the activity
against S. aureus, C14-KYR-NH2 from this study exhibited relatively
lower activity (25 μM, Table 1) than other ultrashort LiPs reported inprevious studies [1]. In those reports, C16-KLLK had MIC 3.12 μM [8],
C16-KGGK and C16-KAAK 8 μM [14], C12-OOWW and C14-OOWW
1.95 μg/mL, where Owas ornithine andWwas tryptophan [9]. and last-
ly, C16-KGK and C20-KGK 8 μg/mL [36] for S. aureus, respectively. The
different MIC values may be due to the different strains of S. aureus
used in our and their studies, and different techniques in determining
theMIC. The presence ofmetal ions in the culturemediamay contribute
to the loss of activity observed in our LiPs as well [42,43].
Next, to determine the kinetics of bacterial killing by LiPs as com-
pared to the positive control antibiotics, the bacterial viability wasmon-
itored at 10 min intervals over 90 min with a LIVE/DEAD BacLight™
bacterial-viability kit (Fig. 5). The results show that at 40 μM, C12- and
C14-KYR-NH2 exhibited killing activity around 80% within the ﬁrst
10 min after treatment, similar to the activity of Gentamicin or poly-
myxin B. This suggested that all bacteria strains except K. pneumoniae
ATCC 17736 were susceptible to C12-KYR-NH2 and C14-KYR-NH2. C12-
and C14-KYR-NH2 at 40 μM showed 70–85% killing activity within
1.5 h in Gram-positive bacteria (S. aureus 1466 and S. epidermidis
ATCC 12228, respectively, Fig. 5A–B), and 85% in Gram-negative bacte-
ria (E. coli O157:H7 ATCC 43895, Fig. 5C). Both LiPs exhibited only 50%
killing activity againstK. pneumoniaeATCC 17736 (Fig. 5D). The fast kill-
ing action supports the possibility of using LiPs as candidates for fast-
acting therapeutics.3.3. Cell selectivity of LiPs
The hemolytic activity of LiPs against the diluted solution of human
erythrocytes is shown in Fig. 6 and summarized in Table 1. All LiPs ex-
hibited a low hemolytic ratio (b10%) within a concentration range of
2 μMto 256 μMand. Unlike LiPs, polymyxin B causedmore than 10% he-
molysis at concentrations above 32 μM. This result indicated that LiPs
displayed cell selectivity toward prokaryotic cells but not human eryth-
rocytes. We further investigated the cellular cytotoxicity of the LiPs
against Vero cells (monkey kidney epithelial cells), and found that all
LiPs exhibited no cytotoxicity at 40 μM but strong cytotoxicity at
80 μM. Our results show a similar pattern with other studies where
C12-OOWW-NH2 exhibited cytotoxicity at 120 μM[9]. At higher concen-
trations, LiPs may interact with the zwitterionic membranes of the eu-
karyotic cells by entropic force rather than electrostatic interaction,
inducing membrane rupture by inserting the hydrocarbon tail into the
lipid bilayer. When considering the length of the hydrocarbon tail,
C12-KYR-NH2 exhibited the least cytotoxicity, indicating that the acyl
chain length of the LiPs is one of the factors in determining their
cytotoxicity.
Next, we analyzed the selectivity of LiPs towards human erythro-
cytes by determining the Selectivity Index (SI) of each LiP. SI is the
ratio of the concentration causing 10% hemolysis (HC10) to the average
MIC80 values of 4 strains tested (GM, geometric index) [41,44]. Higher SI
values indicatemore selective LiPs. As shown in Fig. 7 and in Table 1, se-
lectivity indices (SI) of LiPs directly correlate with inhibitory activity.
This phenomenon was especially marked for C14-KYR-NH2, which ex-
hibited the highest SI (10.24), whereas the parental peptide, KYR-NH2,
had SI 8 times lower than that of C14-KYR-NH2. The SI of C16-KYR-NH2
was also low (0.8), indicating that it was inactive. Its low hemolytic ac-
tivity and high antimicrobial activity suggests that C14-KYR-NH2 may
have potential for use in antimicrobial drug development, but with as
low concentration as possible if used in order to avoid cytotoxicity to
other types of host cells. It is generally known that cationic AMPs and
some LiPs electrostatically interact with the acidic phospholipids
found on the outer leaﬂet of the bacterial membrane. On the other
hand, these AMPs and LiPs appeared to have much lower binding afﬁn-
ity to the mammalian cells, since the membrane components are com-
posed of zwitterionic phospholipids. Therefore, AMPs and LiPs have a
preferential activity or selectivity against bacteria, fungi, and even
some protozoa [45,46].
Fig. 5. The bacterial viability kinetic after treatedwith LiPs (A; S. aureusATCC 25923, B; S. epidermidisATCC 12228, C; E. coliO157:H7 and D; K. pneumoniaATCC 17736)was determined by
using LIVE/DEAD® BacLight™ bacteria viability Kits. The bacterial suspension of 1 × 107 CFU/ml was treated with 40 μM of series LiPs at 37 °C and the ﬂuorescence was measured every
10 min for 90 min. The percentage of dead cells was calculated from the ratio of green (Sytox green) to red ﬂuorescence (Propidium iodide). 100% cell death was calculated from cells
treated with 0.5% Triton-X 100. The excitation and emission wavelengths were 485 nm and 530 nm for green ﬂuorescence and 603 nm for red ﬂuorescence, respectively. The % dead
cells was (1− RatioG / R) ∗ 100, where RatioG / R= Fcell, em1 / Fcell, em2. Fcell, em1 is the integrated intensity of the portion of green ﬂuorescence and Fcell, em2 is em1 is the integrated
intensity of the portion of red ﬂuorescence.
Fig. 6. Effect of LiPs on eukaryotic cells. (A) Hemolytic activities of LiPs. Human erythrocyteswere incubated in PBSwith various concentrations of each LiP for 1 h at 37 °C. The hemoglobin
release wasmonitored with a microplate reader bymeasuring the absorbance at 405 nm. (B) Cytotoxic activities of LiPs. Effect of LiPs on cell viability was determined by MTT assay. Vero
cell were cultivated for 24 h with the 20 and 80 μM concentrations of antimicrobial peptide. There were three duplicated experiments. Data are presented as mean ± SD. The overall P-
value was determined using 1-way ANOVA. * P b 0.05 and ** P= 0.000 different each concentration of peptide vs. control (T-test).
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Fig. 7. Structure–activity relationship (black) and selectivity index (gray). The percentage
of LiP activity in the left Y axis was chosen from the antimicrobial activity values at the
40 μM of each LiP after treated with bacterial cells for 60 min. Selectivity index (SI) in
the right Y axis was calculated from (HC10)/GM.
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3.4.1. Permeabilization and depolarization studies
To investigate the membrane-permeabilization ability of LiPs, we
followed the ﬂuorescence of two probes, N-phenyl-1-naphthylamineFig. 8. Permeabilization of the bacterial membrane; the permeated outer membrane was obser
ence of 20 μMLiPs, and NPN ﬂuorescencewasmonitored at ex/em 350/429 nm for 60min. The
imum ﬂuorescence intensity after 0.001% TTX-100 treatment. The inner membrane permeabil
speciﬁcally binds to DNA after inner membrane disintegration, resulting in an increase of the ﬂ
LiPs containing 5 μM SYTOX® Green. The excitation and emission wavelengths were 504 nm a(NPN) for outer membrane permeability and SYTOX® Green for inner
membrane permeability of bacterial cells after treatment with LiPs.
NPN exhibited weak ﬂuorescence in an aqueous environment, but
strong ﬂuorescence in the hydrophobic environment of a membrane
after partitioning into the disrupted outer membrane. An increase in
NPN ﬂuorescence was observed due to outer membrane disintegration
by LiP permeabilization. Following outer membrane permeabilization,
LiPs may penetrate deeper into the inner membrane leading to inner
membrane disruption. This phenomenon can be followed by using the
SYTOX®Green ﬂuorescent dye that can penetrate into the disintegrated
inner membrane to give higher ﬂuorescence when binding to the geno-
mic DNA inside the bacterial cells.
Our results show that C12-, C14-, and C16-KYR-NH2 had the ability to
disrupt the outer membrane of E. coli O157:H7 ATCC 43895 (Fig. 8A)
within 3 min, as seen by the rapid increase in NPN ﬂuorescence up to
50% of the maximum ﬂuorescence. After 3 min, the ﬂuorescence inten-
sity was stable until at least 60min. C10-KYR-NH2 and KYR-NH2 did not
exert outer membrane permeabilization in E. coli O157:H7. When ana-
lyzing the correlation between killing activity and outermembrane per-
meability, we found that with little outer membrane permeability in
Gram negative bacteria and little cytoplasmic membrane permeability
in Gram positive bacteria, C10-KYR-NH2 and KYR-NH2 also show little
activity in killing the bacteria (40% and 20%, respectively). C16-KYR-
NH2, in contrast, showed discrepancy of such correlation. It had effectiveved by NPN uptake. E. coli O157:H7 (A) suspensions were incubated with NPN in the pres-
ﬂuorescence intensity upon lipopeptide treatment is reported as a percentage of themax-
ity in E. coli O157:H7 (B) and S. aureus ATCC 25923 (C) study used SYTOX® Green which
uorescence intensity. Cell suspensions were incubated with the 20 μM ﬁnal concentration
nd 523 nm, respectively, and recorded at every 3 minute interval.
Fig. 9.Depolarization of the cytoplasmicmembrane of intact E. coliO157:H7 (A and C) and S. aureus ATCC 25923. (B and D) upon exposure to LiPs monitored by the change in the intensity of
ﬂuorescence emission of the DiBAC4(3), cationic membrane potential probe (excitation wavelength = 493 nm, emission wavelength = 516 nm). Bacterial suspensions of 1 × 107 CFU/mL
were incubatedwith 10, 20 and 40 μMof series LiPs at 37 °C for 120min in A and B, and 20 μM for indicated time in C andD. The ﬂuorescencewas recorded at every 15minute interval. Values
are the means of three independent experiments ± S.D. values (error bars).
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This is not very surprising to us since it has been shown that the long
acyl chain in the ultrashort LiPs could lead to the formation of aggregate
structures of the LiPs. These aggregates are thought to be unable to tra-
verse across the outer membrane to further induce inner membrane
disruption [8].
Unlike quick and stable outer membrane permeabilization, LiPs ex-
hibited a more dynamic manner for inner and cytoplasmic membrane
permeabilization (Fig. 8B and C, respectively). Within the 60-minute
time frame of observation, all LiPs could induce permeabilization of the
innermembrane of E. coliO157:H7ATCC 43895 (Fig. 8B) and cytoplasmic
membrane of S. aureus 1466, respectively (Fig. 8C). C14-KYR-NH2 perme-
abilization was the fastest, giving highest inner membrane permeability
within 3 min, as shown by strong ﬂuorescence of SYTOX® Green. After
that, the ﬂuorescence slowly increased until reaching saturation after
20 min, indicating slow penetration of the dye through the inner mem-
brane. C12-KYR-NH2 effectively permeated the inner membrane within
the ﬁrst 10 min, reaching to the levels similar to C14-KYR-NH2 after
20 min. C16-KYR-NH2 rarely showed inner membrane permeabilization
within the ﬁrst 20–30 min, but it eventually reached levels equivalent
to those of C12-KYR-NH2 and C14-KYR-NH2 after 60 min.
Our ﬁndings demonstrated some characteristics of LiPs that have
never been observed before. First, there is little relationship betweenthe outer and inner membrane permeabilization activities of each LiP.
Although most LiPs permeated the outer membrane with similar rates,
they showed remarkably different inner membrane permeabilization
rates. Second, the killing activity of the LiPs correlated directly with
innermembrane permeability, but only if permeabilization could be ob-
servedwithin the ﬁrst 10min of LiP treatment. Our study found that the
ranking of the LiPs from highest to lowest killing activity was: C14-KYR-
NH2 N C12-KYR-NH2 N C10-KYR-NH2 N C16-KYR-NH2= KYR-NH2 (Figs. 5
and 8C and D). Even though C16-KYR-NH2 could cause similarly high
levels of inner membrane permeabilization after a longer period of
time (Fig. 8D), this late permeabilization appeared not to affect the via-
bility of the bacterial cells even after 10 min of incubation (Fig. 5). This
ﬁnding demonstrated that the fatty acid length is important for the LiP
ability to traverse across the membrane. The chain length could be
long enough to allow the maximum disruption, but it may not relate
to the killing activity in case of C16-KYR-NH2.
Maintenance of membrane polarity is essential for bacteria to selec-
tively balance the electrolytes between the outside and inside environ-
ments of the cell. Loss of physical integrity of the membrane due to LiP
attack leads to loss of membrane polarity, and eventual uncontrollable
ion balance. This phenomenon is called membrane depolarization
[47]. To assess the membrane depolarization ability of the LiPs, we
followed the ﬂuorescence of the membrane-potential-sensitive dye,
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time-dependent manner. An increase in the ﬂuorescence intensity of
DiBAC4(3) is proportional to the degree of membrane potential reduc-
tion [47]. At 40 μM, C14-KYR-NH2 induced the greatest depolarization
of the bacterial membrane of both E. coli O157:H7 ATCC 43895 and
S. aureus 1466, while little or no depolarization was observed for KYR-
NH2 and C16-KYR-NH2 (Fig. 9A and B). Membrane depolarization was
stably saturated after 15 min treatment by all LiPs. The results demon-
strate that membrane depolarization ability of LiPs was dependent on
the fatty acid length and concentration, but not time. In addition, our re-
sults indicate that besides having the strongest killing activity, outer and
inner membrane permeabilization ability, C14-KYR-NH2 also has the
strongest membrane depolarization activity, albeit its activity was not
as high as that of PMB.
Whereas the majority of antibacterial LiP studies focused on struc-
ture–activity relationship of LiPs and ultrashort LiPs [9,14,35], our
study demonstrates the relationship between the chain length and the
killing activity of LiPs with a mechanistic explanation of how chain
length affect the activity. In general, LiPs act via twomajormechanisms:
1) inhibiting the synthesis of the compounds in the cell wall structure
such as glucan or chitin, and 2) inducing membrane disintegration
[48]. The acylation in LiPs modiﬁes the overall hydrophobicity of the
molecule, affecting their oligomeric states both in solution and onmem-
brane [49]. Once interacting with the membrane, these oligomers
should be capable of dissociating in order to permeate and cause mem-
brane depolarization, to an eventual membrane disintegration [16]. Dif-
ferent chain length plays a pivotal role in modulating LiP activity via
different extent of membrane permeability as seen in this study. We
were able to correlate the chain length with three correspondingmem-
brane disruption mechanisms: outer membrane permeability, inner
membrane permeability, and membrane depolarization, in a time-
course manner. The results indicate that the optimal length of the
fatty acid to allow most effective membrane disruption in this study is
12–14 carbon atom.
3.5. Effect of KYR-NH2 and C14-KYR-NH2 on bacterial membranes observed
by AFM
Live cells in buffer were attached onto cover glasses under physio-
logical conditions in order to visualize the effect of active LiPs on theseFig. 10. Atomic force microscope image (5 μm × 5 μm) of mid-logarithmic E. coli HB101 illustra
20 μM C14-KYR-NH2 (E, F, I and J) for 15 and 30 min, respectively. C14-KYR-NH2 induced cell s
while KYR-NH2 treatment resulted in maintained shape of rod cell (D and H).cells. 20 μM of either KYR-NH2 or C14-KYR-NH2 was incubated with
live E. coli HB 101 cells on the cover glass for 15 min or 30 min. Images
of the cell surface were then taken, and processed to be deﬂection im-
ages with atomic force microscopy (Asylum Research, USA). Based on
the AFM image of E. coliHB 101 shown in Fig. 10, C14-KYR-NH2 could in-
duce a roughness on the cell surface as evidenced by the elongated,
wrinkled, and severely ruptured cell morphology (Fig. 10F and J), in
contrast to the untreated cells which exhibited a normal smooth surface
(Fig. 10A and B). Treating live cells with KYR-NH2 resulted in bacterial
surfaces that were minimally damaged, giving a cellular morphology
similar to that observed in untreated cells (Fig. 10D andH). This is clear-
ly demonstrated by our AFM results that showed that C14-KYR-NH2
causes surface damage that correspondedwell with themembrane per-
meabilization experiments mentioned earlier in this section.
To summarize the mechanism of how LiPs kill the microorganisms
tested, we propose the model illustrated in Fig. 11. C12- and C14-KYR-
NH2 are ﬁrst bound to the outer membrane of the bacterial cell, within
3 min they permeabilized into the outer membrane. C12 and C14-KYR-
NH2 further induced inner (cytoplasmic) membrane permeability and
also completely depolarized the bacterial membrane of both E. coli
O157:H7 ATCC 43895 and S. aureus 1466, indicating that they severely
affect the viability of the pathogen, resulting in death within 10 min.
The killing ability ranked as C14-KYR-NH2 N C12-KYR-NH2 N C10-KYR-
NH2 N C16-KYR-NH2 = KYR-NH2. It has also been noted that neither
the hydrophobicity of the acyl chain nor the length of the aliphatic moi-
ety directly correlates with the biological function of the peptides [9].
For example, the less hydrophobic LiP C14-KYR-NH2 is more potent
than the longest acyl chain length, C16-KYR-NH2. C14-KYR-NH2 was ac-
tive against Gram-positive bacteria, whereas the more hydrophobic
C16-KYR-NH2 is not active in any experiment.
4. Conclusion
Generally, modiﬁcation of peptides by changing the amino acid se-
quence or by alternating their order within the sequence has been
shown to increase antimicrobial activity. A large body of studies have
been published in which AMPs are rationally designed by swapping
and/or truncating amino acids in order to obtain more potent AMPs.
In contrast, AMP activity improvement by modifying the peptides
with other biomolecules such as carbohydrates and lipids are in theirting untreated cells (A and B) and cells treated with 20 μM KYR-NH2 (C, D, G and H) and
urface damage and severe rupture after treatment for 15 and 30 min as shown in F and J
Fig. 11.Model of LiP actionmechanism. The ﬁgure depicts themain step in the interaction and permeabilization of the bacterial membrane by the series of LiPs (KYR-NH2, C10-, C12-, C14-,
and C16-KYR-NH2). All LiPs adopt a deﬁned secondary structure in the hydrophobic environment. All LiPs attract to the bacterial surface with electrostatic bonding between the positively
charged peptide and the negatively charged bacterialmembrane. Then all LiPs except KYR can permeate the innermembranewithin 3min and inducemembrane depolarization. Bacterial
cell death with severely deformed shape occurs within 10 min, with C14-KYR possessing highest killing and permeating activity.
2363S. Nasompag et al. / Biochimica et Biophysica Acta 1848 (2015) 2351–2364early steps. This study expands on the proof-of-concept of modifying
peptides with lipids in order to yield higher antimicrobial activity com-
pared to the parent unmodiﬁed peptides. Lipid modiﬁcation of AMPs
can improve their antimicrobial activity, increase their in vivo efﬁcacy
and retention, and lower the cost of their manufacture. By adding an
acyl chain to modify the ultrashort peptide, our study demonstrates
the potent antibacterial activity of the modiﬁed LiPs. Addition of an
acyl chain of 12–14 carbon atoms in length gave the highest antibacte-
rial activity, indicating that hydrophobicity is a key parameter dictating
the biological activity of this peptide. Importantly, our study also dem-
onstrates that the aliphatic peptide part and hydrophobic lipid part of
the LiPs had towork together to allowmembrane destabilization, depo-
larization, and eventual disintegration — all of which are similar to the
primary steps in the killing mechanism of a typical AMP.
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